Finance

Lists
Why is MRVI up 5,33%?
Dive Deeper
MRVI:NASDAQ
Maravai Lifesciences Holdings Inc
7,90 US$
+5,33%
(+0,40) 1D
2 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVI...
Open
7,62 US$
High
7,92 US$
Low
7,50 US$
Mkt. cap
2,05 მლრდ.
Avg. vol.
3,74 მლნ.
Volume
0,00
52-wk high
9,42 US$
52-wk low
2,57 US$
EPS
-0,53 US$
Beta
0,54
Shares outstanding
148,99 მლნ.
No. of employees
415
Open
7,62 US$
High
7,92 US$
Low
7,50 US$
Mkt. cap
2,05 მლრდ.
Avg. vol.
3,74 მლნ.
Volume
0,00
52-wk high
9,42 US$
52-wk low
2,57 US$
EPS
-0,53 US$
Beta
0,54
Shares outstanding
148,99 მლნ.
No. of employees
415
News stories
From web sources and news partners
Insider Monkey
Insider Monkey
·
10 საათის წინ
What Is Maravai’s (MRVI) Comeback Really Worth to Investors?
About Maravai Lifesciences Holdings Inc
CEO-
Employees415
Founded2014
Headquarters-
SectorHealth care
Analyst ratings
Based on 5 analysts giving stock ratings to MRVI in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MRVI in the last 3 months.
Highest
Current 7,90 US$
8,00 US$ (+1,27%)
Average
7,50 US$ (-5,06%)
Lowest
6,50 US$ (-17,72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
09/15/2026
Unknown Analyst
UBS
Hold
Initiated
8,00 US$
+1,3%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
8,00 US$
+1,3%
09/09/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
8,00 US$
+1,3%
08/11/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
6,50 US$
-17,7%
08/07/2026
Matt Larew
William Blair
Hold
Reiterated
-
-
08/07/2026
Subbu Nambi
Guggenheim
Hold
Maintained
-
-
05/11/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
6,00 US$
-24,1%
05/08/2026
Catherine Ramsey Schulte
Robert W. Baird
Hold
Maintained
3,00 US$
-62%
02/26/2026
Unknown Analyst
Jefferies
Buy
Reiterated
5,00 US$
-36,7%
02/26/2026
Last report
6 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,02 US$ / -0,05 US$
+55,84%beat
Revenue / Est. (USD)
51,44 მლნ. / 49,52 მლნ.
+3,88%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
41,63 მლნ.
49,87 მლნ.
65,84 მლნ.
51,44 მლნ.
Cost of goods sold
35,98 მლნ.
35,32 მლნ.
32,14 მლნ.
30,79 მლნ.
Cost of revenue
35,98 მლნ.
35,32 მლნ.
32,14 მლნ.
30,79 მლნ.
Research and development expenses
3,84 მლნ.
3,79 მლნ.
3,89 მლნ.
3,70 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35,40 მლნ.
30,38 მლნ.
29,09 მლნ.
32,07 მლნ.
Operating expense
39,24 მლნ.
34,17 მლნ.
32,98 მლნ.
35,77 მლნ.
Total operating expenses
75,22 მლნ.
69,50 მლნ.
65,12 მლნ.
66,56 მლნ.
Operating income
-33,58 მლნ.
-19,63 მლნ.
720,00 ათ.
-15,12 მლნ.
Other non operating income
-71,00 ათ.
-43,00 ათ.
-494,00 ათ.
-52,00 ათ.
EBT including unusual items
-45,15 მლნ.
-63,01 მლნ.
-6,53 მლნ.
-21,80 მლნ.
EBT excluding unusual items
-37,70 მლნ.
-23,84 მლნ.
-3,65 მლნ.
-18,82 მლნ.
Income tax expense
-92,00 ათ.
6,00 ათ.
-151,00 ათ.
-171,00 ათ.
Effective tax rate
0,20%
-0,01%
2,31%
0,78%
Other operating expenses
-
-
-
-
Net income
-25,56 მლნ.
-35,68 მლნ.
-3,73 მლნ.
-12,42 მლნ.
Net profit margin
-61,39%
-71,55%
-5,67%
-24,14%
Earnings per share
-0,08
-0,04
0,01
-0,02
Interest and investment income
2,80 მლნ.
2,38 მლნ.
1,87 მლნ.
1,16 მლნ.
Interest expense
-6,84 მლნ.
-6,56 მლნ.
-5,75 მლნ.
-4,81 მლნ.
Net interest expenses
-4,05 მლნ.
-4,17 მლნ.
-3,88 მლნ.
-3,65 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-20,40 მლნ.
-7,18 მლნ.
12,09 მლნ.
-3,34 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები